Population Health, Equity & Outcomes is our newest journal featuring content on health equity, population health, and improved outcomes.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Clinical Outcomes, Mortality Risk Factor of RSV, Influenza in Hospitalized Adults
Women’s Awareness of ACA Preventive Services Remains Low Amid Ongoing Legal Challenges
Cost Savings From an mHealth Tool for Improving Medication Adherence
Women’s Awareness of ACA Preventive Services Remains Low Amid Ongoing Legal Challenges
Health Equity & Access Weekly Roundup: October 19, 2024
How the Clinical Trial Gender Gap Affects Women’s Heart Care
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
Expanding Access to NSCLC Innovations: Challenges and Opportunities
Data Show Undocumented Latinx People Face Disproportionate Burden of Long COVID
Early Intervention, Targeted Strategies Needed to Improve Disparities, Survival in Patients With IPF
Misdiagnosis of Bipolar Disorder and the Impact on Patient Treatment
Access Has Improved for Diverse Patients Needing Umbilical Cord Blood Transplant, but Disparities Remain
CHEST 2024 Posters Reveal Disparities in Acute Coronary Syndrome Care, Outcomes
Factors Impacting Use of HER2 Therapies for NSCLC
Impact of IPF on Quality of Life and Financial Considerations
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
Exploring the Kidney-CHAMP Study
Rise of Innovative Therapies for Breast Cancer Treatment
A Look at Cancers Where Biomarkers Are Needed
Bridging the Digital Divide of Rural Cancer Care With Telehealth
HER2- Mutation Testing Considerations and Timing
EOM Improved Over OCM, but Challenges Remain for Practices
Improving Access to Lupus Nephritis Treatment: Strategies and Resources
Cost Savings From an mHealth Tool for Improving Medication Adherence
The Daily Balancing Act of Value-Based Cancer Care
Transforming Value-Based Oncology Care in an Evolving Therapeutic Landscape
Putting a Spotlight on Innovation, Collaboration in Specialty Value-Based Care
Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer
Impact of Functional Recovery on Patients Having Heart Surgery
Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs
Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries
COPD Treatment Ratio: A Measure for Improving COPD Population Health
Healthy State: Practicing What They Preach in Louisiana
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way
Navigating the Evolving Treatment Landscape of Metastatic Renal Cell Carcinoma
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction